Analysts at JPMorgan Chase & Co. assumed coverage on shares of Dentsply International Inc. (NASDAQ:XRAY) in a report issued on Thursday. The brokerage set a “neutral” rating on the stock.

Other equities analysts have also issued research reports about the company. Credit Suisse Group AG reissued a “buy” rating on shares of Dentsply International in a report on Sunday, June 26th. Piper Jaffray Cos. assumed coverage on Dentsply International in a report on Monday, June 13th. They set an “overweight” rating and a $70.00 price target on the stock. Jefferies Group reissued a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Barrington Research lowered Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Finally, Zacks Investment Research lowered Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $67.00.

Dentsply International (NASDAQ:XRAY) opened at 59.89 on Thursday. The firm’s 50 day moving average price is $60.83 and its 200-day moving average price is $61.57. The firm has a market cap of $13.96 billion, a PE ratio of 28.10 and a beta of 1.40. Dentsply International has a one year low of $49.48 and a one year high of $65.83.

Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.06. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s quarterly revenue was up 46.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 earnings per share. Equities analysts predict that Dentsply International will post $2.76 EPS for the current fiscal year.

In other news, SVP Maureen J. Macinnis sold 45,100 shares of Dentsply International stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now directly owns 36,730 shares in the company, valued at approximately $2,224,001.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Rainer Berthan sold 5,000 shares of Dentsply International stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total transaction of $305,600.00. Following the sale, the vice president now owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Several large investors have recently bought and sold shares of XRAY. Nisa Investment Advisors L.L.C. increased its stake in Dentsply International by 105.8% in the first quarter. Nisa Investment Advisors L.L.C. now owns 44,942 shares of the company’s stock worth $2,770,000 after buying an additional 23,101 shares during the last quarter. Buffington Mohr McNeal increased its position in shares of Dentsply International by 63.3% in the first quarter. Buffington Mohr McNeal now owns 9,025 shares of the company’s stock valued at $556,000 after buying an additional 3,500 shares in the last quarter. Mn Services Vermogensbeheer B.V. bought a new position in shares of Dentsply International during the first quarter valued at about $326,000. Aperio Group LLC increased its position in shares of Dentsply International by 115.7% in the first quarter. Aperio Group LLC now owns 106,750 shares of the company’s stock valued at $6,579,000 after buying an additional 57,270 shares in the last quarter. Finally, Telemus Capital LLC bought a new position in shares of Dentsply International during the first quarter valued at about $482,000. Institutional investors own 94.58% of the company’s stock.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.